Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_assertion type Assertion NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_head.
- NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_assertion description "[However, after treatment of newborn hMRP8-AML1-ETO transgenic mice and their wild-type littermates with a strong DNA-alkylating mutagen, N-ethyl-N-nitrosourea, 55% of transgenic mice developed AML and the other 45% of transgenic mice and all of the wild-type littermates developed acute T lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_provenance.
- NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_assertion evidence source_evidence_literature NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_provenance.
- NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_assertion SIO_000772 11526243 NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_provenance.
- NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_assertion wasDerivedFrom befree-20140225 NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_provenance.
- NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_assertion wasGeneratedBy ECO_0000203 NP801770.RAW60RcimLL1x9Bgd2d5FKh0f3kmz_njjBt4agjMvz_y0130_provenance.